Your browser doesn't support javascript.
loading
Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions.
Hendriks, William T; Warren, Curtis R; Cowan, Chad A.
Afiliação
  • Hendriks WT; The Collaborative Center for X-Linked Dystonia Parkinsonism, Department of Neurology, Massachusetts General Hospital, Charlestown, MA 02129, USA; Harvard Brain Science Initiative, Harvard Medical School, Boston, MA 02114, USA.
  • Warren CR; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.
  • Cowan CA; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: chad_cowan@harvard.edu.
Cell Stem Cell ; 18(1): 53-65, 2016 Jan 07.
Article em En | MEDLINE | ID: mdl-26748756
ABSTRACT
Human pluripotent stem cells (hPSCs) with knockout or mutant alleles can be generated using custom-engineered nucleases. Transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 nucleases are the most commonly employed technologies for editing hPSC genomes. In this Protocol Review, we provide a brief overview of custom-engineered nucleases in the context of gene editing in hPSCs with a focus on the application of TALENs and CRISPR/Cas9. We will highlight the advantages and disadvantages of each method and discuss theoretical and technical considerations for experimental design.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Genoma Humano / Técnicas Genéticas / Células-Tronco Pluripotentes / Sistemas CRISPR-Cas Limite: Humans Idioma: En Revista: Cell Stem Cell Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Genoma Humano / Técnicas Genéticas / Células-Tronco Pluripotentes / Sistemas CRISPR-Cas Limite: Humans Idioma: En Revista: Cell Stem Cell Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos